SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Psoriasis/Chronic Inflammation
An SI Board Since February 2001
Posts SubjectMarks Bans
631 42 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
206Celltech / Biogen / CDP571 / Crohns Message 17374122nigel bates-4/24/2002
205XNVA / Genentech / OX40 Message 17368213nigel bates-4/23/2002
204Expert Opin Biol Ther 2002 Apr;2(4):431-41 Selective targeting of T cell subsescaram(o)uche-4/22/2002
203sound familiar??....... J Immunol 1998 Apr 15;160(8):3797-804 Potent apoptotiscaram(o)uche-4/22/2002
202Alefacept, an Immunomodulatory Recombinant LFA-3/IgG1 Fusion Protein, Induces CDmichael_f_murphy-4/22/2002
201Morphosys / CD54 Message 17363098 ...MorphoSys will present details of its firstnigel bates-4/22/2002
200Isotechnika's ISAtx247 molecule is being tested on psoriasis. The web cast oteevee-4/18/2002
199Inflammation & Protein Kinases in Drug Discovery & Development sim1-4/18/2002
198Over a gram of antibody gives sub-par results. Why weekly dosing? It's fulscaram(o)uche-4/12/2002
197Psoriasis Patients in Genmab's HuMax-CD4 Phase II Trial Experience Long LastIcebrg-4/12/2002
196Abbott / D2E7 (Adalimumab) BLA ABBOTT PARK, Ill., April 9 /PRNewswire-FirstCallnigel bates-4/9/2002
195OT - indications neurodegenerative Subject 52733michael_f_murphy-4/7/2002
194Mike....OT: Should you start a neuro ...here is my first entry.... "Gila MArthur Radley-4/7/2002
193(off topic - cont) Seems to be all there are -- perhaps we need to start an neurmichael_f_murphy-4/6/2002
192(off topic) is this a complete list? the ever-faithful SI search engine only tscaram(o)uche-4/6/2002
191Xoma, Genentech Warn FDA Filing for Psoriasis Treatment Likely Will Be Delayed Arthur Radley-4/5/2002
190I know that we're supposed to limit chat, but..... wow. sheesh.scaram(o)uche-4/5/2002
189Genentech and XOMA Obtain Results From Xanelim --Efalizumab-- Pharmacokinetic StArthur Radley-4/5/2002
188Finally some positive news from BTRN....I wonder why it has taken over a week toArthur Radley-4/2/2002
187Eric Ende @ Bank of America reports from AAD (February 25, 2002). Ice bofasecuIcebrg-4/1/2002
186Biogen Announces Meeting of FDA Advisory Committee to Review AMEVIVE(R) (AlefaceArthur Radley-4/1/2002
185>> Another failure in the psoriasis area << fwiw, I don't know scaram(o)uche-3/20/2002
184Another failure in the psoriasis area.. Protein Design psoriasis drug fails in Arthur Radley-3/20/2002
183[ice list] If mild to moderate counts . . . Connetics' Olux (clobetatuck-3/11/2002
182ice list this list is almost identical to one published in the npf bulletin(notsoftware salesperson-3/10/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News